G. Parmentier

ImmunTraCkeR® as a reliable TCR repertoire profiling tool to understand immune response and to explore immunotherapy biomarkers

O. Filipe-Santos, Manuarii Manuel, Solène Perez, 2013, Journal of Immunotherapy for Cancer.

2012 Landes Bioscience. Do not distribute. Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

J. Blay, J. Pierga, I. Ray-Coquard, 2012 .

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

J. Blay, J. Pierga, I. Ray-Coquard, 2012, Oncoimmunology.